Cargando…

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report

BACKGROUND: The use of immunomodulating therapy to treat various cancers has been on the rise and these immune checkpoint inhibitors are known to cause ocular side effects. In this article a case of acute exudative polymorphous vitelliform maculopathy (AEPVM) is reported which developed during a fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambert, Ine, Fasolino, Giuseppe, Awada, Gil, Kuijpers, Robert, ten Tusscher, Marcel, Neyns, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180044/ https://www.ncbi.nlm.nih.gov/pubmed/34090381 http://dx.doi.org/10.1186/s12886-021-02011-4

Ejemplares similares

Acute exudative polymorphous vitelliform maculopathy: To bolus or not to bolus?
por: Grenga, Pier Luigi, et al.
Publicado: (2018)

Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma
por: Gameiro Filho, Aluisio Rosa, et al.
Publicado: (2021)

Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate
por: Gao, Jie, et al.
Publicado: (2020)

Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Insight into Imaging Features and Outcomes
por: Torres-Costa, Sónia, et al.
Publicado: (2020)

Imaging features and functional outcome in a case of idiopathic acute exudative polymorphous vitelliform maculopathy
por: Sommer, Michael, et al.
Publicado: (2020)

Exudative Polymorphous Vitelliform Retinopathy: Importance of Early Recognition of the Condition in Patients with Metastatic Melanoma
por: Lincoff, Norah, et al.
Publicado: (2016)

A Case of Goldenhar Syndrome Associated with a New Retinal Presentation: Exudative Vitelliform Maculopathy
por: Bruè, Claudia, et al.
Publicado: (2015)

PARANEOPLASTIC VITELLIFORM MACULOPATHY – ASSOCIATION WITH PRIMARY CANCERS
Publicado: (2018)

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
por: Vermeulen, Sim, et al.
Publicado: (2021)

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS(Q61R/K/L) Mutant Melanoma (TraMel-WT)
por: Awada, Gil, et al.
Publicado: (2021)

Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [(18)F]FDG PET/CT Imaging and Clinical Features
por: Dirks, Ine, et al.
Publicado: (2023)

Pembrolizumab for the treatment of uveal melanoma: A case series
por: Jansen, Yanina Jeanne Leona, et al.
Publicado: (2020)

Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study
por: Fasolino, Giuseppe, et al.
Publicado: (2023)

Adaptive optics ophthalmoscopy, multifocal ERG and OCTA in unique case of suspected torpedo maculopathy presenting with vitelliform lesion
por: Lambert, Nathan G., et al.
Publicado: (2020)

Dolichoectatic arterial compression of the chiasm and optic nerve: a case report
por: Ceuppens, Sara, et al.
Publicado: (2023)

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
por: de Filette, Jeroen, et al.
Publicado: (2016)

“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
por: Narala, Ramsudha, et al.
Publicado: (2020)

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
por: Awada, Gil, et al.
Publicado: (2021)

A case of von Hippel-Lindau disease with exudative maculopathy
por: Ba′arah, Basel T.
Publicado: (2009)

Exudative maculopathy in presumed X-linked retinoschisis with review of literature
por: Ramamurthy, Srishti, et al.
Publicado: (2022)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Subthreshold laser treatment for retinal arterial macroaneurysm associated with exudative maculopathy
por: Bhat, Parvez Ahmad, et al.
Publicado: (2019)

Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors
por: Rogiers, Anne, et al.
Publicado: (2019)

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
por: Barnhart, Carrie
Publicado: (2015)

Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma
por: Dollin, Yonatan, et al.
Publicado: (2020)

Multimodal Image Analysis in Acquired Vitelliform Lesions and Adult-Onset Foveomacular Vitelliform Dystrophy
por: Rocha Bastos, Ricardo, et al.
Publicado: (2016)

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
por: Rogiers, Anne, et al.
Publicado: (2020)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma
por: Ferguson, Ian, et al.
Publicado: (2019)

Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)

Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report
por: Fasolino, Giuseppe, et al.
Publicado: (2022)

Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy
por: Mansour, Ahmad, et al.
Publicado: (2011)

Photodynamic Therapy-Induced Acute Exudative Maculopathy (PAEM): Prevalence, Impact and Management Strategies
por: Sumnicht, Andrew J, et al.
Publicado: (2022)

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients
por: Broggi, Maria A.S., et al.
Publicado: (2019)

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse
por: Jansen, Yanina J. L., et al.
Publicado: (2021)

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
por: Cogen, Anna L., et al.
Publicado: (2018)

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
por: Zhang, Qi, et al.
Publicado: (2020)

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy
por: Seremet, Teofila, et al.
Publicado: (2019)

Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
por: Marín-Lambíes, Cristina, et al.
Publicado: (2012)

Early anatomical changes and association with photodynamic therapy induced acute exudative maculopathy in patients with macular diseases
por: Honda, Satoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_066f9v8ceh19pbbanjq6m1g6c9